Paolo Milani
Clinical trials sponsored by Paolo Milani, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Heart rhythm risks in ATTR amyloidosis patients on tafamidis under scrutiny Results expected Jan 2027 (estimated)